MeSH Review:
Influenza A Virus, H3N8 Subtype
- Attenuation of equine influenza viruses through truncations of the NS1 protein. Quinlivan, M., Zamarin, D., García-Sastre, A., Cullinane, A., Chambers, T., Palese, P. J. Virol. (2005)
- Efficacy of equine influenza vaccines for protection against A/Equine/Jilin/89 (H3N8)--a new equine influenza virus. Webster, R.G., Thomas, T.L. Vaccine (1993)
- Defective influenza A virus generated entirely from plasmids: its RNA is expressed in infected mouse lung and modulates disease. Duhaut, S.D., Dimmock, N.J. J. Virol. Methods (2003)
- Safety and immunogenicity of recombinants based on the genetically-engineered vaccinia strain, NYVAC. Tartaglia, J., Cox, W.I., Pincus, S., Paoletti, E. Dev. Biol. Stand. (1994)
- A dominant Th epitope in influenza nucleoprotein. Analysis of the fine specificity and functional repertoire of T cells recognizing a single determinant. Gao, X.M., Liew, F.Y., Tite, J.P. J. Immunol. (1990)
- Experimental infection of ponies with equine influenza A2 (H3N8) virus strains of different pathogenicity elicits varying interferon and interleukin-6 responses. Wattrang, E., Jessett, D.M., Yates, P., Fuxler, L., Hannant, D. Viral Immunol. (2003)
- Separation of hemagglutinin and neuraminidase from influenza virus membrane by column displacement electrophoresis (isotachophoresis) with preservation of their activities. Johansson, G., Abusugra, I., Lövgren, K., Morein, B. Prep. Biochem. (1988)
- Antibody responses of horses to equine influenza viruses during a postepizootic period in Japan. Goto, H., Shimizu, K., Taya, Y., Noda, H., Tokunaga, T. Can. J. Comp. Med. (1982)